These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33367629)

  • 1. Analytical approaches to minimizing immeasurable time bias in cohort studies.
    Oh IS; Baek YH; Jeong HE; Filion KB; Shin JY
    Int J Epidemiol; 2021 Jul; 50(3):987-999. PubMed ID: 33367629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An empirical assessment of immeasurable time bias in the setting of nested case-control studies: Statins and all-cause mortality among patients with heart failure.
    Oh IS; Filion KB; Jeong HE; Shin JY
    Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1318-1327. PubMed ID: 31432599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validating an approach to overcome the immeasurable time bias in cohort studies: a real-world example and Monte Carlo simulation study.
    Oh IS; Jeong HE; Lee H; Filion KB; Noh Y; Shin JY
    Int J Epidemiol; 2023 Oct; 52(5):1534-1544. PubMed ID: 37172269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical Approaches to Reduce Selection Bias in As-Treated Analyses with Missing In-Hospital Drug Information.
    Baek YH; Noh Y; Oh IS; Jeong HE; Filion KB; Lee H; Shin JY
    Drug Saf; 2022 Oct; 45(10):1057-1067. PubMed ID: 35978219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New methodological approaches were able to effectively reduce immeasurable time bias in case-only designs.
    Jeong HE; Oh IS; Lee H; Filion KB; Shin JY
    J Clin Epidemiol; 2021 Mar; 131():1-10. PubMed ID: 33171274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immeasurable time bias due to hospitalization in medico-administrative databases: which impact for pharmacoepidemiological studies?
    Palmaro A; Boucherie Q; Dupouy J; Micallef J; Lapeyre-Mestre M
    Pharmacoepidemiol Drug Saf; 2017 May; 26(5):544-553. PubMed ID: 28266748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.
    Weberpals J; Jansen L; van Herk-Sukel MPP; Kuiper JG; Aarts MJ; Vissers PAJ; Brenner H
    Eur J Epidemiol; 2017 Nov; 32(11):1019-1031. PubMed ID: 28864947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited impact of drug exposure misclassification from non-benefit thiazolidinedione drug use on mortality and hospitalizations from Saskatchewan, Canada: a cohort study.
    Gamble JM; Johnson JA; McAlister FA; Majumdar SR; Simpson SH; Eurich DT
    Clin Ther; 2015 Mar; 37(3):629-42. PubMed ID: 25596665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11,942 elderly patients with heart failure.
    Sin DD; McAlister FA
    Am J Med; 2002 Dec; 113(8):650-6. PubMed ID: 12505115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis.
    Zhou H; Sim JJ; Shi J; Shaw SF; Lee MS; Neyer JR; Kovesdy CP; Kalantar-Zadeh K; Jacobsen SJ
    Am J Kidney Dis; 2021 May; 77(5):704-712. PubMed ID: 33010357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
    Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
    Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
    Perreault S; de Denus S; White M; White-Guay B; Bouvier M; Dorais M; Dubé MP; Rouleau JL; Tardif JC; Jenna S; Haibe-Kains B; Leduc R; Deblois D
    Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):81-90. PubMed ID: 27859924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of uncertain exposure-A method to define switching and add-on in pharmacoepidemiology.
    Pazzagli L; Linder M; Reutfors J; Brandt L
    Pharmacoepidemiol Drug Saf; 2022 Jan; 31(1):28-36. PubMed ID: 34558772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of beta-blockers and risk of contralateral breast cancer.
    Gottschau M; Bens A; Friis S; Cronin-Fenton D; Aalborg GL; Jensen MB; Ejlertsen B; Kroman N; Mellemkjaer L
    Int J Cancer; 2022 May; 150(10):1619-1626. PubMed ID: 34985760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
    Lund LH; Benson L; Dahlström U; Edner M; Friberg L
    JAMA; 2014 Nov; 312(19):2008-18. PubMed ID: 25399276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immeasurable Time Bias in Self-controlled Designs: Case-crossover, Case-time-control, and Case-case-time-control Analyses.
    Jeong HE; Lee H; Oh IS; Filion KB; Shin JY
    J Epidemiol; 2023 Feb; 33(2):82-90. PubMed ID: 34053964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY
    Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-related biases in pharmacoepidemiology.
    Suissa S; Dell'Aniello S
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1101-1110. PubMed ID: 32783283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.
    Bhatia V; Bajaj NS; Sanam K; Hashim T; Morgan CJ; Prabhu SD; Fonarow GC; Deedwania P; Butler J; Carson P; Love TE; Kheirbek R; Aronow WS; Anker SD; Waagstein F; Fletcher R; Allman RM; Ahmed A
    Am J Med; 2015 Jul; 128(7):715-21. PubMed ID: 25554369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between beta-blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score-matched analysis from the Swedish Heart Failure Registry.
    Stolfo D; Uijl A; Benson L; Schrage B; Fudim M; Asselbergs FW; Koudstaal S; Sinagra G; Dahlström U; Rosano G; Savarese G
    Eur J Heart Fail; 2020 Jan; 22(1):103-112. PubMed ID: 31478583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.